BAJAJ BROKING

Notification
No new Notification messages
Vishal Mega Mart IPO is Open!
Apply for the Vishal Mega Mart IPO through UPI in just minutes.
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
NSE BSE
procter & gamble health l stock

PROCTER & GAMBLE HEALTH L Share Price

5583.5 -16.50 (-0.29%)
Dec 12 2024 12:59 PM Pharmaceuticals NSE: PGHL

PROCTER & GAMBLE HEALTH L Share Price Update

As of the latest trading session, PROCTER & GAMBLE HEALTH L share price is currently at 5583.5, which is down by -16.50 from its previous closing. Today, the stock has fluctuated between 5547.10 and 5634.30. Over the past year, PROCTER & GAMBLE HEALTH L has achieved a return of 12.68 %. In the last month alone, the return has been 2.45 %. Read More...

PROCTER & GAMBLE HEALTH L Performance

Day Range

Low5547.10 High5634.30
5566.75

52 Week Range

Low 4636.55 High 5833.30
5566.75

PROCTER & GAMBLE HEALTH L Share Price

940

500126

PGHL

img img img img
No Data Available

Open Price

5634.30

Prev. Close

5600.00

Volume (Shares)

1175.00

Total traded value

65.40

Upper Circuit

6720.00

Lower Circuit

4480.00

Note: The current prices & values are delayed, Login to your account for live updates.

PROCTER & GAMBLE HEALTH L Fundamentals


(Standalone)

Market Cap (Cr) 9239.10
PE Ratio (TTM) 42.61
Book Value / Share 324.25
Beta 0.32
ROE 31.18%
EPS (TTM) 136.52
Dividend Yield 4.65%
Net Profit Qtr (Cr) 82.33

PROCTER & GAMBLE HEALTH L Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition

Revenue

Net income

Particulars SEP 2024 (Values in Cr)
Revenue 313.41
Operating Expense 205.29
Net Profit 82.33
Net Profit Margin (%) 26.26
Earnings Per Share (EPS) 49.60
EBITDA 117.32
Effective Tax Rate (%) 26.09
Particulars JUN 2024 (Values in Cr)
Revenue 283.88
Operating Expense 242.98
Net Profit 16.78
Net Profit Margin (%) 5.91
Earnings Per Share (EPS) 9.50
EBITDA 30.18
Effective Tax Rate (%) 26.50
Particulars MAR 2024 (Values in Cr)
Revenue 252.48
Operating Expense 192.03
Net Profit 46.56
Net Profit Margin (%) 18.44
Earnings Per Share (EPS) 28.00
EBITDA 69.71
Effective Tax Rate (%) 25.76
Particulars DEC 2023 (Values in Cr)
Revenue 309.97
Operating Expense 215.43
Net Profit 72.07
Net Profit Margin (%) 23.25
Earnings Per Share (EPS) 43.40
EBITDA 106.83
Effective Tax Rate (%) 27.72
Particulars SEP 2023 (Values in Cr)
Revenue 304.93
Operating Expense 222.93
Net Profit 65.57
Net Profit Margin (%) 21.50
Earnings Per Share (EPS) 39.50
EBITDA 94.71
Effective Tax Rate (%) 25.53
Particulars JUN 2024 (Values in Cr)
Revenue 1151.26
Operating Expense 873.38
Net Profit 200.98
Net Profit Margin (%) 17.45
Earnings Per Share (EPS) 133.24
EBITDA 301.44
Effective Tax Rate (%) 26.46
Particulars JUN 2023 (Values in Cr)
Revenue 1229.62
Operating Expense 933.81
Net Profit 229.47
Net Profit Margin (%) 18.66
Earnings Per Share (EPS) 138.23
EBITDA 343.07
Effective Tax Rate (%) 26.96
Particulars JUN 2022 (Values in Cr)
Revenue 1114.41
Operating Expense 874.22
Net Profit 192.52
Net Profit Margin (%) 17.27
Earnings Per Share (EPS) 115.98
EBITDA 280.87
Effective Tax Rate (%) 24.01
Particulars JUN 2021 (Values in Cr)
Revenue 1008.73
Operating Expense 793.55
Net Profit 176.80
Net Profit Margin (%) 17.52
Earnings Per Share (EPS) 106.50
EBITDA 264.12
Effective Tax Rate (%) 24.21
Particulars JUN 2020 (Values in Cr)
Revenue 1355.86
Operating Expense 1069.90
Net Profit 254.08
Net Profit Margin (%) 18.73
Earnings Per Share (EPS) 153.10
EBITDA 384.30
Effective Tax Rate (%) 28.39
Particulars JUN 2024 (Values in Cr)
Book Value / Share 324.24
ROE % 31.18
ROCE % 39.76
Total Debt to Total Equity 0.02
EBITDA Margin 26.18
Particulars JUN 2023 (Values in Cr)
Book Value / Share 452.34
ROE % 33.56
ROCE % 43.16
Total Debt to Total Equity 0.01
EBITDA Margin 27.90
Particulars JUN 2022 (Values in Cr)
Book Value / Share 371.38
ROE % 29.17
ROCE % 35.97
Total Debt to Total Equity 0.01
EBITDA Margin 25.20
Particulars JUN 2021 (Values in Cr)
Book Value / Share 423.92
ROE % 21.96
ROCE % 27.53
Total Debt to Total Equity 0.00
EBITDA Margin 26.18
Particulars JUN 2020 (Values in Cr)
Book Value / Share 545.99
ROE % 13.85
ROCE % 18.81
Total Debt to Total Equity 0.00
EBITDA Margin 28.34
Particulars JUN 2024 (Values in Cr)
Cash & Short Term Investments 244.36
Total Assets 794.36
Total Liabilities 794.36
Total Equity 538.24
Share Outstanding 16599382
Price to Book Ratio 15.57
Return on Assets (%) 25.30
Return on Capital (%) 37.34
Particulars JUN 2023 (Values in Cr)
Cash & Short Term Investments 440.22
Total Assets 1101.19
Total Liabilities 1101.19
Total Equity 750.89
Share Outstanding 16599382
Price to Book Ratio 11.60
Return on Assets (%) 20.83
Return on Capital (%) 30.56
Particulars JUN 2022 (Values in Cr)
Cash & Short Term Investments 324.53
Total Assets 888.12
Total Liabilities 888.12
Total Equity 616.49
Share Outstanding 16599382
Price to Book Ratio 11.27
Return on Assets (%) 21.67
Return on Capital (%) 31.23
Particulars JUN 2021 (Values in Cr)
Cash & Short Term Investments 468.91
Total Assets 986.16
Total Liabilities 986.16
Total Equity 703.71
Share Outstanding 16599382
Price to Book Ratio 13.20
Return on Assets (%) 17.92
Return on Capital (%) 25.12
Particulars JUN 2020 (Values in Cr)
Cash & Short Term Investments 639.09
Total Assets 1175.74
Total Liabilities 1175.74
Total Equity 906.34
Share Outstanding 16599382
Price to Book Ratio 7.45
Return on Assets (%) 21.61
Return on Capital (%) 28.03
Particulars JUN 2024 (Values in Cr)
Net Income 273.32
Cash from Operations 313.47
Cash from Investing -6.87
Cash from Financing -418.10
Net change in Cash -196.69
Free Cash Flow 335.20
Particulars JUN 2023 (Values in Cr)
Net Income 314.20
Cash from Operations 325.67
Cash from Investing -21.50
Cash from Financing -98.49
Net change in Cash 116.02
Free Cash Flow 368.15
Particulars JUN 2022 (Values in Cr)
Net Income 253.37
Cash from Operations 233.38
Cash from Investing -25.54
Cash from Financing -288.63
Net change in Cash -144.65
Free Cash Flow 271.30
Particulars JUN 2021 (Values in Cr)
Net Income 233.28
Cash from Operations 315.38
Cash from Investing -32.27
Cash from Financing -386.63
Net change in Cash -171.64
Free Cash Flow 367.96
Particulars JUN 2020 (Values in Cr)
Net Income 354.85
Cash from Operations 336.96
Cash from Investing 164.64
Cash from Financing -883.41
Net change in Cash -483.40
Free Cash Flow 360.22
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 65.16 37.45 3.55 499.34 37.54 / 77.70
BLISS GVS PHARMA LTD 151.80 19.00 1.58 1598.94 92.25 / 172.40
CIPLA LTD 1454.20 25.44 4.14 117443.01 1192.85 / 1702.00
FERMENTA BIOTECH LIMITED 410.00 142.36 4.15 1206.67 145.00 / 440.00
GLAXOSMITHKLINE PHARMA LT 2345.45 49.56 23.75 39733.34 1664.75 / 3087.95
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 65.16 56.66 11.07 499.34 37.54 / 77.70
AMRUTAJAN HEALTH LTD 749.55 45.59 7.27 2167.00 556.05 / 861.40
ASTRAZENECA PHARMA IND LT 6595.05 128.08 24.26 16487.63 4050.15 / 8139.85
BLISS GVS PHARMA LTD 151.80 19.79 1.56 1598.94 92.25 / 172.40

Technicals

  • EMA & SMA
  • Resistance and Support
  • Price Change Analysis
- redarrow -
red-green-graph indicator
Bullish Moving Averages -
Bearish Moving Averages -
  • 5 Days 5563.00
  • 26 Days 5357.90
  • 10 Days 5461.60
  • 50 Days 5349.10
  • 12 Days 5428.30
  • 100 Days 5283.00
  • 20 Days 5395.80
  • 200 Days 5048.20
5613.73
PIVOT
First Resistance 5670.47
Second Resistance 5740.93
Third Resistance 5797.67
First Support 5543.27
Second Support 5486.53
Third Support 5416.07
RSI 62.08
MACD 70.37
Commodity Channel Index (CCI) 133.90
ADX 32.32
Williams % R -19.39

Over 1 Month

down

2.45

Over 3 Months

down

3.84

Over 6 Months

down

12.14

Over 1 Year

down

12.68

Over 3 Years

down

2.19

Over 5 Years

down

6.27

PROCTER & GAMBLE HEALTH L Future

Future: Price

25 May
0 100 200 300 400 500 600

Discount/Premium

25 May
0 1 2 3 4 5 6 7

Active Calls

25 May
0 500 1000 1500 2000 2500 3000

Active Puts

25 Jul
0 500 1000 1500 2000 2500

PROCTER & GAMBLE HEALTH L Shareholding Pattern

  • Shareholding Summary
  • Historical Promotor Holding
  • Historical MF Holding
  • Historical FII Holding

Holding

Public
26.73
Promoter Holdings
51.81
FII
6.6
DII
14.83
Promoter Shares(Pledge Percentage)
0.0
Name Category Shares Shares%
Procter And Gamble Overseas India B.v. Shareholding of Promoter and Promoter Group 8601071.0 51.82
Nippon Life India Trustee Ltd-a/c Nippon India Sma Public Shareholding 680942.0 4.1
Icici Prudential Mnc Fund Public Shareholding 433271.0 2.61
Lici Asm Non Par Public Shareholding 412731.0 2.49
Uti-mnc Fund Public Shareholding 314378.0 1.89
Merck Internationale Beteiligungen Gmbh Shareholding of Promoter and Promoter Group 0.0 0.0
Emedia Export Company Shareholding of Promoter and Promoter Group 0.0 0.0
Chemitra Gesellschaft Mit Beschrankter Haftung Shareholding of Promoter and Promoter Group 0.0 0.0

PROCTER & GAMBLE HEALTH L

  • Dividend
  • Bonus
  • Split
Ex-Date Dividend Amt. Dividend Type Record Date Instrument Type
2024-02-14 50.0 Interim 2024-02-14 Equity shares 2024-02-14 150.0 Special 2024-02-14 Equity shares 2023-11-23 50.0 Final 2023-11-24 Equity shares 2023-02-13 45.0 Interim 2023-02-13 Equity shares 2022-11-15 11.5 Final 2022-11-17 Equity shares 2022-05-12 41.0 Interim 2022-05-13 Equity shares 2021-11-02 40.0 Final 2021-11-05 Equity shares 2021-11-02 90.0 Special 2021-11-05 Equity shares 2020-11-18 42.0 Final 2020-11-20 Equity shares 2020-11-18 188.0 Special 2020-11-20 Equity shares 2019-05-23 24.0 Final 2019-05-25 Equity shares 2019-05-23 416.0 Special 2019-05-25 Equity shares 2018-05-21 15.0 Final 2018-05-23 Equity shares 2017-05-25 11.0 Final 2017-05-29 Equity shares 2016-04-22 7.5 Final 2016-04-26 Equity shares 2015-03-30 6.0 Final 2015-04-06 Equity shares 2014-03-10 8.5 Final 2014-03-12 Equity shares 2013-03-07 2.5 Final 2013-03-09 Equity shares 2010-10-22 95.0 Interim 2010-10-25 Equity shares 2010-03-18 20.0 Final 2010-03-20 Equity shares 2009-04-06 17.5 Final 2009-04-09 Equity shares 2008-04-04 10.0 Final 2008-04-08 Equity shares 2007-03-21 20.0 Final 2007-03-23 Equity shares 2007-03-21 10.0 Interim 2007-03-23 Equity shares 2006-04-12 0.0 Final 2006-04-15 Equity shares
Ex-Date Ex-Bonus Ratio
Ex-Date Old FV NEW FV Record Date

Learn More About Stocks

About PROCTER & GAMBLE HEALTH L

Read More
  • Management structure
  • Board of directors
  • Committees of the board of directors

Companies Owned by PROCTER & GAMBLE HEALTH L

We have something for everyone

Explore More Investment Options

Stocks

Secure and enhance your financial future today

investment-card-icon

IPOs

Your gateway to future financial opportunities

investment-card-icon

MTF

Explore Buy Now Pay Later and boost your capital by up to 4x  

investment-card-icon

US Stocks

Discover opportunities to invest in elite FAANG stocks

investment-card-icon

Frequently Asked Questions

What is the Share Price of Procter & Gamble Health Ltd?

Answer Field

The share price of Procter & Gamble Health Ltd for NSE is ₹ 5583.5 and for BSE is ₹ 5592.4.

What is the Market Cap of Procter & Gamble Health Ltd?

Answer Field

The market cap of Procter & Gamble Health Ltd for NSE is ₹ 92,39.10 Cr. and for BSE is ₹ 0.0 Cr. as of now.

What is the 52 Week High and Low of Procter & Gamble Health Ltd?

Answer Field

The 52 Week High and Low of Procter & Gamble Health Ltd for NSE is ₹ 5833.30 and ₹ 4636.55 and for BSE is ₹ 5835.95 and ₹ 4640.30.

How to Buy Procter & Gamble Health Ltd share?

Answer Field

You can trade in Procter & Gamble Health Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Procter & Gamble Health Ltd?

Answer Field

The 1 year returns on the stock has been 12.68%.

What is the Current Share Price of Procter & Gamble Health Ltd?

Answer Field

Procter & Gamble Health Ltd share price is for NSE ₹ 5583.5 & for BSE ₹ 5592.4 as on Dec 12 2024 12:59 PM.

What is the Market Cap of Procter & Gamble Health Ltd Share?

Answer Field

The market cap of Procter & Gamble Health Ltd for NSE ₹ 92,39.10 & for BSE ₹ 0.0 as on Dec 12 2024 12:59 PM.

What is the P/E Ratio of Procter & Gamble Health Ltd Share?

Answer Field

As on Dec 12 2024 12:59 PM the price-to-earnings (PE) ratio for Procter & Gamble Health Ltd share is 42.61.

What is the PB ratio of Procter & Gamble Health Ltd Share?

Answer Field

As on Dec 12 2024 12:59 PM, the price-to-book (PB) ratio for Procter & Gamble Health Ltd share is 324.25.

How to Buy Procter & Gamble Health Ltd Share?

Answer Field

You can trade in Procter & Gamble Health Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Procter & Gamble Health Ltd Share on Bajaj Broking App?

Answer Field

To buy Procter & Gamble Health Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Procter & Gamble Health Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

8 Lacs+ Users

icon-with-text

4.4+ App Rating

icon-with-text

4 Languages

icon-with-text

₹4700+ Cr MTF Book

icon-with-text
loader